不可切除的卵巢癌的临床试验
总计26129个结果
-
Women's Hospital School Of Medicine Zhejiang University主动,不招人
-
Universitaire Ziekenhuizen KU LeuvenAstraZeneca主动,不招人
-
Chang Gung Memorial HospitalHoffmann-La Roche; Asian Gynecologic Oncology Group; Taiwanese Gynecolgic Oncology Group完全的
-
Sunesis Pharmaceuticals完全的
-
Vanderbilt UniversityNational Cancer Institute (NCI); Celgene Corporation完全的
-
AbbVie (prior sponsor, Abbott)Biogen完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)终止
-
Weill Medical College of Cornell University未知
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)终止输卵管腺癌 | 输卵管移行细胞癌 | 卵巢腺癌 | 输卵管透明细胞腺癌 | 输卵管子宫内膜样腺癌 | 输卵管粘液腺癌 | 输卵管浆液性腺癌 | 恶性卵巢布伦纳瘤 | 原发性腹膜浆液性腺癌 | 恶性卵巢透明细胞瘤 | 恶性卵巢子宫内膜样瘤 | 恶性卵巢粘液性肿瘤 | 恶性卵巢混合性上皮瘤 | 未分化卵巢癌 | IIIA 期输卵管癌 | IIIA期卵巢癌 | IIIA 期原发性腹膜癌 | IIIB 期输卵管癌 | IIIB期卵巢癌 | IIIB 期原发性腹膜癌 | IIIC 期输卵管癌 | IIIC 期卵巢癌 | IIIC 期原发性腹膜癌 | IV 期输卵管癌 | IV 期卵巢癌 | IV 期原发性腹膜癌 | 恶性卵巢肿瘤 | 恶性卵巢浆液性肿瘤 | 恶性卵巢移行细胞瘤 | 未分化输卵管癌美国
-
University of British Columbia完全的
-
Fondazione Policlinico Universitario Agostino Gemelli...招聘中
-
Mario Negri Institute for Pharmacological ResearchHoffmann-La Roche; PharmaMar完全的
-
Shanghai Gynecologic Oncology Group招聘中
-
The University of Texas Health Science Center at...终止
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)完全的
-
Cancer Hospital of Guangxi Medical University主动,不招人
-
Fondazione Policlinico Universitario Agostino Gemelli...招聘中
-
Far Eastern Memorial Hospital完全的
-
Fondazione Policlinico Universitario Agostino Gemelli...未知
-
University of California, IrvinePatient-Centered Outcomes Research Institute完全的
-
Fred Hutchinson Cancer CenterFox Chase Cancer Center; City of Hope Medical Center; Stanford University; Cedars-Sinai Medical... 和其他合作者完全的